Valuation: Mega Lifesciences

Market Cap 28.77B 861M 765M 709M 645M 1.22B 81.72B 1.24B 8.53B 3.34B 42.64B 3.23B 3.16B 136B P/E 2026 *
12.6x
P/E 2027 * 11.6x
Enterprise Value 24.15B 723M 643M 596M 542M 1.02B 68.6B 1.04B 7.16B 2.81B 35.8B 2.71B 2.66B 114B EV / Sales 2026 *
1.69x
EV / Sales 2027 * 1.55x
Free-Float
38.66%
Yield 2026 *
5.4%
Yield 2027 * 5.78%
1 day+0.76%
1 week-2.22%
Current month-2.22%
1 month-8.33%
3 months-13.16%
6 months-2.94%
Current year-1.49%
1 week 32.5
Extreme 32.5
33.75
1 month 32.5
Extreme 32.5
36.75
Current year 31.5
Extreme 31.5
40
1 year 28.25
Extreme 28.25
40
3 years 24.3
Extreme 24.3
46
5 years 24.3
Extreme 24.3
56.5
10 years 17.9
Extreme 17.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 01/01/1988
Director of Finance/CFO 62 01/01/1997
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 62 01/01/1998
Director/Board Member 64 01/01/2013
Director/Board Member 73 01/02/2013
Date Insider Type Main position Quantity % Market Cap. Importance
4/29/25 A Buy

Chief Executive Officer

100,000 0.0115%
4/28/25 A Buy

Chief Executive Officer

50,000 0.0057%
4/28/25 A Buy

Chief Executive Officer

150,000 0.0172%
Change 5-day change 1-year change 3-year change Capi.($)
+0.76%-2.22%+13.79%-25.42% 861M
+0.43%+6.59%+53.41%+103.85% 1,120B
+0.90%-2.25%+33.02%+62.23% 616B
+0.71%+3.24%+25.81%+93.86% 504B
-0.13%+5.98%+32.91%+50.39% 367B
+0.52%+0.24%+73.92%+40.15% 360B
-0.95%+4.70%+19.51%+43.00% 288B
-1.98%+3.73%-0.86%+13.43% 258B
-0.35%+4.25%+46.21%+50.76% 234B
-0.75%+3.32%+32.53%+97.21% 194B
Average -0.08%+3.18%+33.03%+52.95% 394.18B
Weighted average by Cap. +0.13%+3.83%+39.17%+71.41%

Financials

2026 *2027 *
Net sales 14.33B 429M 381M 353M 321M 607M 40.7B 616M 4.25B 1.67B 21.24B 1.61B 1.58B 67.71B 15.5B 464M 412M 382M 348M 656M 44.02B 667M 4.59B 1.8B 22.97B 1.74B 1.7B 73.23B
Net income 2.24B 67.12M 59.67M 55.3M 50.32M 94.95M 6.37B 96.47M 665M 261M 3.32B 252M 247M 10.6B 2.49B 74.39M 66.13M 61.29M 55.76M 105M 7.06B 107M 737M 289M 3.68B 279M 273M 11.75B
Net Debt -4.62B -138M -123M -114M -104M -195M -13.11B -199M -1.37B -536M -6.84B -519M -507M -21.81B -4.72B -141M -126M -116M -106M -200M -13.4B -203M -1.4B -548M -7B -530M -519M -22.3B
Projected Income Statement - Annual - Mega Lifesciences
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
15/10/26 THB 33.00 +0.76% 893,356
14/10/26 THB 32.75 -0.76% 1,316,354
12/10/26 THB 33.00 -2.22% 2,183,479
09/10/26 THB 33.75 +1.50% 179,733
08/10/26 THB 33.25 -0.75% 458,564
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Mega Lifesciences
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
33.00THB
Average target price
42.71THB
Spread / Average Target
+29.44%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Mega Lifesciences
  1. Stock Market
  2. Stocks
  3. MEGA Stock